Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 20, 2012
Primary chemotherapy for inoperable ovarian, fallopian tube, or primary peritoneal cancer with or without delayed debulking surgery
Antonio Saha, Mohini Varughese, Chris J Gallagher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 25, 2010
International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)
Akila N Viswanathan, Carien L Creutzberg, Peter Craighead, et al.
The Lancet. Oncology
|
October 18, 2015
Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial
R Paul Symonds, Charlie Gourley, Susan Davidson, et al.
Cancers
|
November 9, 2024
Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London
Karim H El-Shakankery, Joanna Kefas, Kieran Palmer, et al.
Oncology
|
June 4, 2016
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer
Charlotte R Lemech, Leah Ensell, Jennifer C Paterson, et al.
Gynecologic Oncology Reports
|
July 18, 2018
Advancing clinical research globally: Cervical cancer research network from Mexico
Bryan J Ager, Dolores Gallardo-Rincón, David Cantú de León, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 10, 2024
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)
Ritu Salani, Mary McCormack, Yong-Man Kim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)
Ritu Salani, Mary McCormack, Yong-Man Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 2023
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice
Domenica Lorusso, Nicoletta Colombo, Antonio Casado Herraez, et al.
Muscle & Nerve
|
March 21, 2025
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral Sclerosis
Grace Addy, Erica Scirocco, Dario Gelevski, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 20, 2012
Primary chemotherapy for inoperable ovarian, fallopian tube, or primary peritoneal cancer with or without delayed debulking surgery
Antonio Saha, Mohini Varughese, Chris J Gallagher, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 25, 2010
International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)
Akila N Viswanathan, Carien L Creutzberg, Peter Craighead, et al.
The Lancet. Oncology
|
October 18, 2015
Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial
R Paul Symonds, Charlie Gourley, Susan Davidson, et al.
Cancers
|
November 9, 2024
Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London
Karim H El-Shakankery, Joanna Kefas, Kieran Palmer, et al.
Oncology
|
June 4, 2016
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer
Charlotte R Lemech, Leah Ensell, Jennifer C Paterson, et al.
Gynecologic Oncology Reports
|
July 18, 2018
Advancing clinical research globally: Cervical cancer research network from Mexico
Bryan J Ager, Dolores Gallardo-Rincón, David Cantú de León, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 10, 2024
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)
Ritu Salani, Mary McCormack, Yong-Man Kim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04)
Ritu Salani, Mary McCormack, Yong-Man Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 22, 2023
Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice
Domenica Lorusso, Nicoletta Colombo, Antonio Casado Herraez, et al.
Muscle & Nerve
|
March 21, 2025
An Expanded Access Protocol of RNS60 in Amyotrophic Lateral Sclerosis
Grace Addy, Erica Scirocco, Dario Gelevski, et al.
Page
of 6